本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Cue Biopharma, Inc.

0.7415
-0.0242-3.16%
盤後0.75630.0148+2.00%17:51 EDT
成交量:36.21萬
成交額:27.03萬
市值:5,698.12萬
市盈率:-1.41
高:0.7779
開:0.7650
低:0.7200
收:0.7657
52周最高:1.99
52周最低:0.4500
股本:7,684.59萬
流通股本:7,658.03萬
量比:3.57
換手率:0.47%
股息:- -
股息率:- -
每股收益(TTM):-0.5267
每股收益(LYR):-0.7221
淨資產收益率:-195.55%
總資產收益率:-59.43%
市淨率:3.14
市盈率(LYR):-1.03

資料載入中...

2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/12

SEC問詢函

CORRESP [Cover] - Correspondence
2022/12/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/15

重要事件披露

8-K - Current report
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/22

重要事件披露

8-K - Current report
2022/06/10

重要事件披露

8-K - Current report
2022/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/30

重要事件披露

8-K - Current report
2022/03/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/18

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/15

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/08

持股變動聲明

4 - Statement of changes in beneficial ownership of securities